{"id":{"repo_id":"ubc","oai_identifier":"oai:circle.library.ubc.ca:2429/17153"},"canonical_url":"https://search.ndltd.org/etd/ubc/oai:circle.library.ubc.ca:2429/17153","repository":{"repo_id":"ubc","name":"University of British Columbia","base_url":"http://circle.library.ubc.ca/oai/request"},"display":{"title":"Mitochondria and microdomains in vascular smooth muscle cell Ca²⁺ signalling","abstract":"Contraction of vascular smooth muscle (VSM) is regulated by fluctuations in the intracellular concentration of free ionic calcium ([Ca²⁺][sub i]). The spatio-temporal regulation of [Ca²⁺][sub i] relies on the sub-cellular architecture of the smooth muscle cell and the juxtaposition of opposing plasmalemma (PM), sarcoplasmic reticulum (SR) and mitochondria. This thesis addresses two related aspects of Ca²⁺-signaling in VSM: 1) basal Ca²⁺-entry across the PM and 2) mitochondrial Ca²⁺-uptake during agonist mediated stimulation in cultured rat aorta smooth muscle cells. Basal Ca²⁺-entry into resting cells, measured with radio-labeled ⁴⁵Ca²⁺, was blocked (~80%) by organic inhibitors of L-type voltage-gated Ca²⁺-channels (nifedipine), store-/receptoroperated Ca²⁺-channels (SKF-96365) and inositol-1,4,5-trisphosphate receptors (IP₃R) (2-APB). At increasing concentrations, gadolium (Gd³⁺) biphasically inhibited Ca²⁺-uptake. The maximal effect of the first phase (100μM Gd³⁺) was equally as effective as combined treatment with 2-APB and SKF-96365. At 0.2-10mM, Gd³⁺ inhibited Ca²⁺ influx to a greater extent than the organic inhibitors. We concluded that basal Ca²⁺ entry primarily occurred via basal activity of excitable channels, and PCR analysis suggests this influx to involve L-type voltage-gated Ca²⁺-channels, and TRPC1, TRPC4 and TRPC6. Next, we used Ca²⁺-sensitive proteins (aequorins and pericams) and dyes (fura-2) to measure parallel [Ca²⁺] changes in the mitochondrial matrix, subplasmalemmal cytosol and bulk cytosol. Replacing extracellular Na⁺ with n-methyl-d-glucamine (NMDG) caused Ca²⁺-entry by reversal of the Na⁺/Ca²⁺-exchanger (NCX), which was selectively blocked by KB-R7943. NCX-reversal increased mitochondrial and subplasmalemmal but not bulk cytosolic [Ca²⁺] revealing a local interaction of the SR, NCX and mitochondria. Furthermore, NCX-reversal and mitochondrial Ca²⁺-uptake appear to occur during the [Ca²⁺][sub i] plateau phase of the response to purinergic stimulation (ATP). However, this mitochondrial Ca²⁺-uptake does not increase [Ca²⁺][sub MT] because of a compensatory stimulation of mitochondrial Ca²⁺-extrusion (blocked by CGP-37157). Finally, we dissected the [Ca²⁺][sub MT] response to SR Ca²⁺-release in response to agonist-mediated stimulation. ATP and [ARG⁸]-vasopressin transiently increased [Ca²⁺][sub MT] by activating both IP₃R and ryanodine receptors (RyR) (selectively inhibited by 2-APB and procaine). Image analysis of fluorescently labeled mitochondria, IP₃R and RyR corroborated functional evidence that IP₃R and RyR release Ca²⁺ from separate sub-compartments of the SR and that physiological [Ca²⁺][sub MT] elevations rely on IP₃R-RyR cross-talk.","abstract_html":"Contraction of vascular smooth muscle (VSM) is regulated by fluctuations in the intracellular concentration of free ionic calcium ([Ca²⁺][sub i]). The spatio-temporal regulation of [Ca²⁺][sub i] relies on the sub-cellular architecture of the smooth muscle cell and the juxtaposition of opposing plasmalemma (PM), sarcoplasmic reticulum (SR) and mitochondria. This thesis addresses two related aspects of Ca²⁺-signaling in VSM: 1) basal Ca²⁺-entry across the PM and 2) mitochondrial Ca²⁺-uptake during agonist mediated stimulation in cultured rat aorta smooth muscle cells. Basal Ca²⁺-entry into resting cells, measured with radio-labeled ⁴⁵Ca²⁺, was blocked (~80%) by organic inhibitors of L-type voltage-gated Ca²⁺-channels (nifedipine), store-/receptoroperated Ca²⁺-channels (SKF-96365) and inositol-1,4,5-trisphosphate receptors (IP₃R) (2-APB). At increasing concentrations, gadolium (Gd³⁺) biphasically inhibited Ca²⁺-uptake. The maximal effect of the first phase (100μM Gd³⁺) was equally as effective as combined treatment with 2-APB and SKF-96365. At 0.2-10mM, Gd³⁺ inhibited Ca²⁺ influx to a greater extent than the organic inhibitors. We concluded that basal Ca²⁺ entry primarily occurred via basal activity of excitable channels, and PCR analysis suggests this influx to involve L-type voltage-gated Ca²⁺-channels, and TRPC1, TRPC4 and TRPC6. Next, we used Ca²⁺-sensitive proteins (aequorins and pericams) and dyes (fura-2) to measure parallel [Ca²⁺] changes in the mitochondrial matrix, subplasmalemmal cytosol and bulk cytosol. Replacing extracellular Na⁺ with n-methyl-d-glucamine (NMDG) caused Ca²⁺-entry by reversal of the Na⁺/Ca²⁺-exchanger (NCX), which was selectively blocked by KB-R7943. NCX-reversal increased mitochondrial and subplasmalemmal but not bulk cytosolic [Ca²⁺] revealing a local interaction of the SR, NCX and mitochondria. Furthermore, NCX-reversal and mitochondrial Ca²⁺-uptake appear to occur during the [Ca²⁺][sub i] plateau phase of the response to purinergic stimulation (ATP). However, this mitochondrial Ca²⁺-uptake does not increase [Ca²⁺][sub MT] because of a compensatory stimulation of mitochondrial Ca²⁺-extrusion (blocked by CGP-37157). Finally, we dissected the [Ca²⁺][sub MT] response to SR Ca²⁺-release in response to agonist-mediated stimulation. ATP and [ARG⁸]-vasopressin transiently increased [Ca²⁺][sub MT] by activating both IP₃R and ryanodine receptors (RyR) (selectively inhibited by 2-APB and procaine). Image analysis of fluorescently labeled mitochondria, IP₃R and RyR corroborated functional evidence that IP₃R and RyR release Ca²⁺ from separate sub-compartments of the SR and that physiological [Ca²⁺][sub MT] elevations rely on IP₃R-RyR cross-talk.","abstract_has_math":false,"creators":["Poburko, Damon Todd"],"institution":"University of British Columbia","degree_name":"Doctor of Philosophy - PhD","degree_level":"doctoral","degree_discipline":"Pharmacology and Therapeutics","degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2005,"date_issued":"2005","date_published":"2005","updated_at":"2026-11-19T14:35:30Z","subjects":[],"languages":["eng"],"rights":["For non-commercial purposes only, such as research, private study and education. Additional conditions apply, see Terms of Use https://open.library.ubc.ca/terms_of_use."],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"http://hdl.handle.net/2429/17153","outbound_label":"Handle","outbound_source":"dc:identifier","record_url":"http://hdl.handle.net/2429/17153","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier","download_url":"http://circle.library.ubc.ca/bitstream/2429/17153/1/ubc_2005-105550.pdf","download_label":"Download PDF","download_source":"dc:identifier","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"http://circle.library.ubc.ca/oai/request?verb=GetRecord&metadataPrefix=etdms&identifier=oai%3Acircle.library.ubc.ca%3A2429%2F17153","prefix":"etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:creator","label":"Author","values":["Poburko, Damon Todd"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2005"]},{"key":"dc:publisher","label":"Institution","values":["University of British Columbia"]},{"key":"dc:type","label":"Dc Type","values":["Text"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Pharmacology and Therapeutics"]},{"key":"thesis:degree_level","label":"Degree Level","values":["doctoral"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Doctor of Philosophy - PhD"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["University of British Columbia"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["eng"]},{"key":"dc:rights","label":"Dc Rights","values":["For non-commercial purposes only, such as research, private study and education. Additional conditions apply, see Terms of Use https://open.library.ubc.ca/terms_of_use."]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["http://hdl.handle.net/2429/17153","http://circle.library.ubc.ca/bitstream/2429/17153/1/ubc_2005-105550.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Contraction of vascular smooth muscle (VSM) is regulated by fluctuations in the intracellular concentration of free ionic calcium ([Ca²⁺][sub i]). The spatio-temporal regulation of [Ca²⁺][sub i] relies on the sub-cellular architecture of the smooth muscle cell and the juxtaposition of opposing plasmalemma (PM), sarcoplasmic reticulum (SR) and mitochondria. This thesis addresses two related aspects of Ca²⁺-signaling in VSM: 1) basal Ca²⁺-entry across the PM and 2) mitochondrial Ca²⁺-uptake during agonist mediated stimulation in cultured rat aorta smooth muscle cells. Basal Ca²⁺-entry into resting cells, measured with radio-labeled ⁴⁵Ca²⁺, was blocked (~80%) by organic inhibitors of L-type voltage-gated Ca²⁺-channels (nifedipine), store-/receptoroperated Ca²⁺-channels (SKF-96365) and inositol-1,4,5-trisphosphate receptors (IP₃R) (2-APB). At increasing concentrations, gadolium (Gd³⁺) biphasically inhibited Ca²⁺-uptake. The maximal effect of the first phase (100μM Gd³⁺) was equally as effective as combined treatment with 2-APB and SKF-96365. At 0.2-10mM, Gd³⁺ inhibited Ca²⁺ influx to a greater extent than the organic inhibitors. We concluded that basal Ca²⁺ entry primarily occurred via basal activity of excitable channels, and PCR analysis suggests this influx to involve L-type voltage-gated Ca²⁺-channels, and TRPC1, TRPC4 and TRPC6. Next, we used Ca²⁺-sensitive proteins (aequorins and pericams) and dyes (fura-2) to measure parallel [Ca²⁺] changes in the mitochondrial matrix, subplasmalemmal cytosol and bulk cytosol. Replacing extracellular Na⁺ with n-methyl-d-glucamine (NMDG) caused Ca²⁺-entry by reversal of the Na⁺/Ca²⁺-exchanger (NCX), which was selectively blocked by KB-R7943. NCX-reversal increased mitochondrial and subplasmalemmal but not bulk cytosolic [Ca²⁺] revealing a local interaction of the SR, NCX and mitochondria. Furthermore, NCX-reversal and mitochondrial Ca²⁺-uptake appear to occur during the [Ca²⁺][sub i] plateau phase of the response to purinergic stimulation (ATP). However, this mitochondrial Ca²⁺-uptake does not increase [Ca²⁺][sub MT] because of a compensatory stimulation of mitochondrial Ca²⁺-extrusion (blocked by CGP-37157). Finally, we dissected the [Ca²⁺][sub MT] response to SR Ca²⁺-release in response to agonist-mediated stimulation. ATP and [ARG⁸]-vasopressin transiently increased [Ca²⁺][sub MT] by activating both IP₃R and ryanodine receptors (RyR) (selectively inhibited by 2-APB and procaine). Image analysis of fluorescently labeled mitochondria, IP₃R and RyR corroborated functional evidence that IP₃R and RyR release Ca²⁺ from separate sub-compartments of the SR and that physiological [Ca²⁺][sub MT] elevations rely on IP₃R-RyR cross-talk."]},{"key":"dc:format","label":"Dc Format","values":["20785351","application/pdf"]},{"key":"dc:title","label":"Title","values":["Mitochondria and microdomains in vascular smooth muscle cell Ca²⁺ signalling"]}]}],"canonical_facts":{"dc:creator":["Poburko, Damon Todd"],"dc:date":["2005"],"dc:description":["Contraction of vascular smooth muscle (VSM) is regulated by fluctuations in the intracellular concentration of free ionic calcium ([Ca²⁺][sub i]). The spatio-temporal regulation of [Ca²⁺][sub i] relies on the sub-cellular architecture of the smooth muscle cell and the juxtaposition of opposing plasmalemma (PM), sarcoplasmic reticulum (SR) and mitochondria. This thesis addresses two related aspects of Ca²⁺-signaling in VSM: 1) basal Ca²⁺-entry across the PM and 2) mitochondrial Ca²⁺-uptake during agonist mediated stimulation in cultured rat aorta smooth muscle cells. Basal Ca²⁺-entry into resting cells, measured with radio-labeled ⁴⁵Ca²⁺, was blocked (~80%) by organic inhibitors of L-type voltage-gated Ca²⁺-channels (nifedipine), store-/receptoroperated Ca²⁺-channels (SKF-96365) and inositol-1,4,5-trisphosphate receptors (IP₃R) (2-APB). At increasing concentrations, gadolium (Gd³⁺) biphasically inhibited Ca²⁺-uptake. The maximal effect of the first phase (100μM Gd³⁺) was equally as effective as combined treatment with 2-APB and SKF-96365. At 0.2-10mM, Gd³⁺ inhibited Ca²⁺ influx to a greater extent than the organic inhibitors. We concluded that basal Ca²⁺ entry primarily occurred via basal activity of excitable channels, and PCR analysis suggests this influx to involve L-type voltage-gated Ca²⁺-channels, and TRPC1, TRPC4 and TRPC6. Next, we used Ca²⁺-sensitive proteins (aequorins and pericams) and dyes (fura-2) to measure parallel [Ca²⁺] changes in the mitochondrial matrix, subplasmalemmal cytosol and bulk cytosol. Replacing extracellular Na⁺ with n-methyl-d-glucamine (NMDG) caused Ca²⁺-entry by reversal of the Na⁺/Ca²⁺-exchanger (NCX), which was selectively blocked by KB-R7943. NCX-reversal increased mitochondrial and subplasmalemmal but not bulk cytosolic [Ca²⁺] revealing a local interaction of the SR, NCX and mitochondria. Furthermore, NCX-reversal and mitochondrial Ca²⁺-uptake appear to occur during the [Ca²⁺][sub i] plateau phase of the response to purinergic stimulation (ATP). However, this mitochondrial Ca²⁺-uptake does not increase [Ca²⁺][sub MT] because of a compensatory stimulation of mitochondrial Ca²⁺-extrusion (blocked by CGP-37157). Finally, we dissected the [Ca²⁺][sub MT] response to SR Ca²⁺-release in response to agonist-mediated stimulation. ATP and [ARG⁸]-vasopressin transiently increased [Ca²⁺][sub MT] by activating both IP₃R and ryanodine receptors (RyR) (selectively inhibited by 2-APB and procaine). Image analysis of fluorescently labeled mitochondria, IP₃R and RyR corroborated functional evidence that IP₃R and RyR release Ca²⁺ from separate sub-compartments of the SR and that physiological [Ca²⁺][sub MT] elevations rely on IP₃R-RyR cross-talk."],"dc:format":["20785351","application/pdf"],"dc:identifier":["http://hdl.handle.net/2429/17153","http://circle.library.ubc.ca/bitstream/2429/17153/1/ubc_2005-105550.pdf"],"dc:language":["eng"],"dc:publisher":["University of British Columbia"],"dc:rights":["For non-commercial purposes only, such as research, private study and education. Additional conditions apply, see Terms of Use https://open.library.ubc.ca/terms_of_use."],"dc:title":["Mitochondria and microdomains in vascular smooth muscle cell Ca²⁺ signalling"],"dc:type":["Text"],"thesis:degree_discipline":["Pharmacology and Therapeutics"],"thesis:degree_level":["doctoral"],"thesis:degree_name":["Doctor of Philosophy - PhD"],"thesis:institution_name":["University of British Columbia"]},"updated_at":"2026-11-19T14:35:30Z"}